Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2012 · fourth_quarter · 4A
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2012 · fourth_quarter · Q4
Source: Senate LDA
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2012 · third_quarter · Q3
S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2012 · second_quarter · Q2
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2012 · first_quarter · Q1
Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIMERIX, INC. via FOLEY HOAG LLP
2012 · second_quarter · RR
Implementation of Project BioShield Act and the Pandemic and All-Hazards Preparedness Act (PAHPA). Education and awareness on smallpox medical countermeasures (MCM).